Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4643 | 1678 | 33.1 | 73% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
56 | 28576 | CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FAMILIAL HYPERCHOLESTEROLEMIA | Author keyword | 239 | 43% | 25% | 422 |
2 | FAMILIAL HYPERCHOLESTEROLAEMIA | Author keyword | 89 | 55% | 7% | 112 |
3 | LDL RECEPTOR GENE | Author keyword | 42 | 75% | 2% | 30 |
4 | FAMILIAL DEFECTIVE APOLIPOPROTEIN B 100 | Author keyword | 36 | 79% | 1% | 23 |
5 | LOW DENSITY LIPOPROTEIN RECEPTOR GENE | Author keyword | 35 | 81% | 1% | 21 |
6 | LOW DENSITY LIPOPROTEIN RECEPTOR | Author keyword | 31 | 24% | 7% | 113 |
7 | LDLR GENE | Author keyword | 28 | 81% | 1% | 17 |
8 | AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA | Author keyword | 27 | 92% | 1% | 11 |
9 | LDL RECEPTOR MUTATIONS | Author keyword | 23 | 86% | 1% | 12 |
10 | LDL RECEPTOR | Author keyword | 22 | 17% | 7% | 121 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEFECTIVE APOLIPOPROTEIN B 100 | 140 | 79% | 5% | 90 |
2 | LDL RECEPTOR GENE | 87 | 52% | 7% | 118 |
3 | B MUTATION | 45 | 94% | 1% | 16 |
4 | CAUSES HYPERCHOLESTEROLEMIA | 32 | 80% | 1% | 20 |
5 | AFRIKANERS | 32 | 78% | 1% | 21 |
6 | ASSOCIATION EXPERT PANEL | 26 | 54% | 2% | 34 |
7 | HUMAN LDL RECEPTOR | 26 | 64% | 1% | 25 |
8 | LIPOPROTEIN RECEPTOR GENE | 24 | 34% | 3% | 58 |
9 | FAMILIAL DEFECTIVE APOLIPOPROTEIN B 100 | 22 | 39% | 3% | 43 |
10 | LDL RECEPTOR | 21 | 11% | 11% | 178 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mechanisms of Disease: genetic causes of familial hypercholesterolemia | 2007 | 172 | 75 | 73% |
Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review | 2004 | 142 | 100 | 88% |
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation | 2014 | 22 | 164 | 40% |
Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment | 2012 | 54 | 44 | 43% |
Familial hypercholesterolemia and coronary heart disease: A HuGE association review | 2004 | 108 | 76 | 78% |
Genetic heterogeneity of autosomal dominant hypercholesterolemia | 2008 | 78 | 75 | 71% |
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia | 2003 | 213 | 77 | 44% |
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society | 2014 | 20 | 54 | 33% |
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia | 2010 | 22 | 10 | 100% |
Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-Lowering therapy | 2014 | 7 | 56 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOMETAB SERV | 15 | 88% | 0.4% | 7 |
2 | UNIDADE ID | 9 | 83% | 0.3% | 5 |
3 | GRP INVEST CARDIOVASC | 8 | 75% | 0.4% | 6 |
4 | BRITISH HEART FDN S | 7 | 18% | 2.1% | 35 |
5 | MRCC E HEART GRP | 6 | 100% | 0.2% | 4 |
6 | PONTAI MED | 6 | 100% | 0.2% | 4 |
7 | UNIT GENET BIOL TORS ATHEROSCLEROSIS | 5 | 54% | 0.4% | 7 |
8 | LIPID DISORDERS CLIN | 5 | 27% | 1.0% | 17 |
9 | INVEST MOL | 5 | 25% | 1.0% | 16 |
10 | CGH MED | 4 | 67% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000269986 | PCSK9//PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9//MIPOMERSEN |
2 | 0.0000213981 | APOLIPOPROTEIN B GENE//APOB GENE//SIGNAL PEPTIDE POLYMORPHISM |
3 | 0.0000142652 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//LIPOPROTEIN APHERESIS |
4 | 0.0000133305 | HYPERTHERMIC SENSITIVITY//CELLULAR CHOLESTEROL CONTENT//HIV 1 THERAPY |
5 | 0.0000096637 | LRP1B//VLDL RECEPTOR//LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN |
6 | 0.0000095944 | FIBROUS PLAQUES//CHOLESTEROL SCREENING//PREVENT SECT |
7 | 0.0000073683 | LIPOPROTEIN GLOMERULOPATHY//APOLIPOPROTEIN E//TYPE III HYPERLIPOPROTEINEMIA |
8 | 0.0000070336 | LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL |
9 | 0.0000067469 | CEREBROTENDINOUS XANTHOMATOSIS//CHOLESTANOL//BILE ALCOHOLS |
10 | 0.0000066375 | JOINT EFFUSIONS//JUMPING HORSE//MED BLOOD TRANSFUS UNIT |